<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>79_Myasthenia gravis and Other Neuromuscular Junct... - Marrow Medicine</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <style>
        .medical-quiz {
            font-family: Segoe UI, Tahoma, Geneva, Verdana, sans-serif;
        }
        
        .question-card {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
        }
        
        .option-card {
            transition: all 0.3s ease;
            cursor: pointer;
            border: 2px solid transparent;
        }
        
        .option-card:hover {
            border-color: #3b82f6;
            transform: translateY(-2px);
        }
        
        .option-card.selected {
            background: #3b82f6;
            color: white;
            border-color: #1d4ed8;
        }
        
        .option-card.correct {
            background: #10b981;
            color: white;
            border-color: #059669;
        }
        
        .option-card.incorrect {
            background: #ef4444;
            color: white;
            border-color: #dc2626;
        }
        
        .progress-bar {
            background: linear-gradient(to right, #10b981, #059669);
            transition: width 0.3s;
        }
        
        .medical-image {
            max-width: 100%;
            max-height: 400px;
            height: auto;
            border-radius: 12px;
            margin: 20px auto;
            display: block;
        }
        
        .hidden {
            display: none !important;
        }

        .explanation-content {
            font-family: Segoe UI, Tahoma, Geneva, Verdana, sans-serif;
            font-size: 1.05rem;
            line-height: 1.7;
            color: #374151;
            text-align: left;
        }
        
        .explanation-content p {
            margin-bottom: 1rem;
            text-align: justify;
        }
        
        .explanation-content strong, .explanation-content b {
            font-weight: 600;
            color: #1f2937;
        }
        
        .explanation-content img {
            max-width: 100%;
            height: auto;
            margin: 1.5rem auto;
            display: block;
            border-radius: 8px;
            box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
        }
    </style>
</head>

<body class="bg-gradient-to-br from-blue-50 to-indigo-100 min-h-screen medical-quiz">
    <header class="bg-white shadow-xl p-6">
        <div class="container mx-auto flex justify-between items-center">
            <div>
                <h1 class="text-3xl font-bold text-gray-800">79_Myasthenia gravis and Other Neuromuscular Junct...</h1>
                <p class="text-gray-600 mt-2">Marrow ‚Ä¢ Medicine ‚Ä¢ Interactive Learning</p>
            </div>
            <div class="flex gap-2">
                <button class="bg-gray-500 text-white px-3 py-2 text-sm rounded-lg hover:bg-gray-600 transition" 
                        onclick="window.location.href='marrow_medicine.html'">
                    ‚Üê Topics
                </button>
                <button class="bg-purple-500 text-white px-3 py-2 text-sm rounded-lg hover:bg-purple-600 transition" 
                        onclick="window.location.href='marrow.html'">
                    üìö Marrow
                </button>
                <button class="bg-blue-500 text-white px-3 py-2 text-sm rounded-lg hover:bg-blue-600 transition" 
                        onclick="window.location.href='index.html'">
                    üè† Home
                </button>
            </div>
        </div>
    </header>

    <!-- Statistics Bar (Hidden in Test Mode) -->
    <div class="bg-white shadow-lg p-4" id="stats-bar">
        <div class="container mx-auto flex justify-center gap-8">
            <div class="text-center">
                <div class="text-2xl font-bold text-green-600" id="correct-stats">0</div>
                <div class="text-sm text-gray-600">Correct</div>
            </div>
            <div class="text-center">
                <div class="text-2xl font-bold text-red-600" id="incorrect-stats">0</div>
                <div class="text-sm text-gray-600">Incorrect</div>
            </div>
            <div class="text-center">
                <div class="text-2xl font-bold text-blue-600" id="accuracy-stats">0%</div>
                <div class="text-sm text-gray-600">Accuracy</div>
            </div>
            <div class="text-center">
                <div class="text-2xl font-bold text-purple-600" id="progress-stats">0/16</div>
                <div class="text-sm text-gray-600">Progress</div>
            </div>
        </div>
    </div>

    <!-- Quiz Section -->
    <section class="container mx-auto p-6" id="quiz-section">
        <div class="bg-white rounded-2xl shadow-xl p-8">
            <!-- Progress Bar -->
            <div class="w-full bg-gray-200 rounded-full h-4 mb-8">
                <div class="progress-bar h-4 rounded-full" id="progress-bar"></div>
            </div>

            <div class="flex justify-between items-center mb-8">
                <h2 class="text-2xl font-bold text-blue-700" id="question-number">Question 1 of 16</h2>
                <div class="text-sm text-gray-600" id="question-status">Click an option to answer</div>
            </div>

            <!-- Question Text -->
            <div class="mb-10">
                <div class="question-card text-white p-8 rounded-2xl mb-8" id="question-text"></div>
                
                <!-- Question Image -->
                <div class="text-center mb-8" id="question-images"></div>
                
                <!-- Options -->
                <div class="space-y-4" id="options"></div>
            </div>

            <!-- Answer Feedback Section (Normal Mode Only) -->
            <div class="hidden mb-8 p-6 rounded-2xl" id="feedback-section">
                <div class="text-center mb-4">
                    <div class="text-6xl mb-2" id="feedback-icon"></div>
                    <div class="text-2xl font-bold mb-2" id="feedback-message">Correct!</div>
                </div>
                
                <div class="grid md:grid-cols-2 gap-4 mb-4">
                    <div class="bg-white p-4 rounded-xl border">
                        <strong>Your Answer:</strong><br>
                        <span id="user-answer-display"></span>
                    </div>
                    <div class="bg-white p-4 rounded-xl border">
                        <strong>Correct Answer:</strong><br>
                        <span class="text-green-600" id="correct-answer-display"></span>
                    </div>
                </div>
                
                <div class="bg-blue-50 p-6 rounded-xl" id="explanation-section">
                    <strong class="text-lg text-blue-800">Explanation:</strong>
                    <div id="explanation-content" class="mt-3 explanation-content"></div>
                </div>
            </div>

            <!-- Navigation -->
            <div class="flex justify-between gap-4">
                <button class="bg-gray-400 text-white px-6 py-3 rounded-xl hover:bg-gray-500 transition" 
                        onclick="window.location.href='marrow_medicine.html'">
                    Back to Topics
                </button>
                
                <div class="flex gap-4">
                    <button class="bg-gray-400 text-white px-6 py-3 rounded-xl disabled" id="prev-btn">
                        Previous
                    </button>
                    <button class="bg-blue-500 text-white px-6 py-3 rounded-xl hidden" id="next-btn">
                        Next
                    </button>
                    <button class="bg-green-600 text-white px-6 py-3 rounded-xl font-bold hidden" id="finish-btn">
                        Finish Quiz
                    </button>
                </div>
            </div>
        </div>
    </section>

    <!-- Test Mode Final Results -->
    <section class="container mx-auto p-6 hidden" id="test-results">
        <div class="bg-white rounded-2xl shadow-xl p-8">
            <div class="text-center mb-8">
                <h2 class="text-4xl font-bold mb-4 text-blue-700">Test Complete! üéâ</h2>
                <div class="text-6xl mb-4" id="test-grade-icon">üéØ</div>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="bg-green-100 p-6 rounded-2xl text-center">
                    <div class="text-4xl font-bold text-green-600" id="test-final-correct">0</div>
                    <div class="font-semibold text-green-700">Correct Answers</div>
                </div>
                <div class="bg-red-100 p-6 rounded-2xl text-center">
                    <div class="text-4xl font-bold text-red-600" id="test-final-incorrect">0</div>
                    <div class="font-semibold text-red-700">Incorrect Answers</div>
                </div>
                <div class="bg-blue-100 p-6 rounded-2xl text-center">
                    <div class="text-4xl font-bold text-blue-600" id="test-final-accuracy">0%</div>
                    <div class="font-semibold text-blue-700">Final Accuracy</div>
                </div>
            </div>

            <!-- Detailed Review -->
            <div class="mb-8">
                <h3 class="text-2xl font-bold text-gray-800 mb-4">üìã Detailed Review</h3>
                <div id="test-review-details" class="space-y-4"></div>
            </div>
            
            <div class="flex justify-center gap-4">
                <button class="bg-purple-600 text-white px-8 py-3 rounded-xl font-bold hover:bg-purple-700 transition" 
                        onclick="window.location.href='marrow_medicine.html'">
                    Back to Topics
                </button>
                <button class="bg-blue-600 text-white px-8 py-3 rounded-xl font-bold hover:bg-blue-700 transition" 
                        onclick="window.location.reload()">
                    Retake Quiz
                </button>
            </div>
        </div>
    </section>

    <!-- Normal Mode Final Results -->
    <section class="container mx-auto p-6 hidden" id="final-results">
        <div class="bg-white rounded-2xl shadow-xl p-8">
            <div class="text-center mb-8">
                <h2 class="text-4xl font-bold mb-4 text-blue-700">Quiz Complete! üéâ</h2>
                <div class="text-6xl mb-4" id="final-grade-icon">üéØ</div>
            </div>
            
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="bg-green-100 p-6 rounded-2xl text-center">
                    <div class="text-4xl font-bold text-green-600" id="final-correct">0</div>
                    <div class="font-semibold text-green-700">Correct Answers</div>
                </div>
                <div class="bg-red-100 p-6 rounded-2xl text-center">
                    <div class="text-4xl font-bold text-red-600" id="final-incorrect">0</div>
                    <div class="font-semibold text-red-700">Incorrect Answers</div>
                </div>
                <div class="bg-blue-100 p-6 rounded-2xl text-center">
                    <div class="text-4xl font-bold text-blue-600" id="final-accuracy">0%</div>
                    <div class="font-semibold text-blue-700">Final Accuracy</div>
                </div>
            </div>
            
            <div class="flex justify-center gap-4">
                <button class="bg-purple-600 text-white px-8 py-3 rounded-xl font-bold hover:bg-purple-700 transition" 
                        onclick="window.location.href='marrow_medicine.html'">
                    Back to Topics
                </button>
                <button class="bg-blue-600 text-white px-8 py-3 rounded-xl font-bold hover:bg-blue-700 transition" 
                        onclick="window.location.reload()">
                    Retake Quiz
                </button>
            </div>
        </div>
    </section>

    <script>
        const questions = [
  {
    "id": 1457,
    "text": "Q1. Myasthenia gravis is associated with which of the following?",
    "options": [
      {
        "label": "A",
        "text": "Decreased acetylcholine release at the nerve endings",
        "correct": false
      },
      {
        "label": "B",
        "text": "Increased acetylcholine release at the nerve endings",
        "correct": false
      },
      {
        "label": "C",
        "text": "Increased synaptic transmission at the myoneural junction",
        "correct": false
      },
      {
        "label": "D",
        "text": "Decreased synaptic transmission at the myoneural junction",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Myasthenia gravis is associated with a decrease in synaptic transmission at the myoneural junction. Myasthenia gravis is a neuromuscular disorder that is characterized by weakness and fatigability of skeletal muscles. It is due to autoantibody-mediated destruction of the acetylcholine receptors (AChRs) at the neuromuscular junction. This consequentially leads to a decreased transmission at the neuromuscular (myoneural) junction.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Decreased synaptic transmission at the myoneural junction"
  },
  {
    "id": 1458,
    "text": "Q2. In myasthenia gravis, the anti-AChR antibodies reduce the number of available AChRs at the neuromuscular junction by all of the following mechanisms except:",
    "options": [
      {
        "label": "A",
        "text": "Accelerated turnover of AChRs",
        "correct": false
      },
      {
        "label": "B",
        "text": "Damage to the postsynaptic muscle membrane",
        "correct": false
      },
      {
        "label": "C",
        "text": "Damage to muscle-specific receptor tyrosine kinase",
        "correct": true
      },
      {
        "label": "D",
        "text": "Blockade of the active site of the AChR",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">In myasthenia gravis, damage to muscle-specific receptor tyrosine kinase is not a mechanism by which anti-AChR antibodies reduce the number of available AChRs at the neuromuscular junction. The anti-AChR antibodies reduce the number of available AChRs at the neuromuscular junction using three distinct mechanisms: * Accelerated turnover of AChRs * Damage to the postsynaptic muscle membrane mediated by antibodies and complement * Blockade of the active site of the AChR Patients whose sera test negative for both AChR and MuSK antibodies possess antibodies specific to another protein at the neuromuscular junction called low-density lipoprotein receptor-related protein 4 (LRP4). LRP4 plays a functional role in the clustering of AChRs. Anti-MuSK antibodies are directed against muscle-specific receptor tyrosine kinase (MuSK), a protein involved in AChR clustering at the neuromuscular junction.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "C. Damage to muscle-specific receptor tyrosine kinase"
  },
  {
    "id": 1459,
    "text": "Q3. Which of the following statements about myasthenia gravis is false?",
    "options": [
      {
        "label": "A",
        "text": "Weakness and fatigability of muscles is present",
        "correct": false
      },
      {
        "label": "B",
        "text": "Complete remissions are seen",
        "correct": true
      },
      {
        "label": "C",
        "text": "Lids and extraocular muscles are involved",
        "correct": false
      },
      {
        "label": "D",
        "text": "Proximal limb weakness is seen",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Remissions may occur spontaneously but are usually not complete or permanent. The cardinal clinical features of myasthenia gravis include: * Women are affected by myasthenia gravis more frequently than men, in a ratio of ~3: 2. * Weakness and fatigability of muscles - Weakness may increase upon repeated use or later in the day. It may improve with rest or sleep. 1175 * Diplopia and ptosis - They are common initial clinical complaints. The cranial muscles, particularly the eyelids and the extraocular muscles, are typically involved early in the course of myasthenia gravis. ¬¢ Limb weakness - It is often proximal and may be asymmetric. * Deep tendon reflexes - They are preserved despite muscle weakness.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "B. Complete remissions are seen"
  },
  {
    "id": 1460,
    "text": "Q4. school teacher presents to the OPD with excessive fatigability and double vision. She says that her symptoms are aggravated towards the end of the day. Her colleagues told her that, lately, she has developed a nasal twang in her voice. Which of the following statements is true 1170 regarding this condition?",
    "options": [
      {
        "label": "A",
        "text": "Thymoma is present in more than 75% of the patients with this condition",
        "correct": false
      },
      {
        "label": "B",
        "text": "In most of the cases the thymus is hypoplastic",
        "correct": false
      },
      {
        "label": "C",
        "text": "Myoid cells in thymus serve as the source of autoantigens",
        "correct": true
      },
      {
        "label": "D",
        "text": "Thymus is abnormal in 20% of patients with AChR antibody‚Äîpositive status",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">The given scenario is suggestive of myasthenia gravis (MG). Myoid cells in the thymus serve as the source of autoantigens in this condition. The muscle-like cells within the thymus called myoid cells, express AChRs on their surface. These cells are known to serve as a source of autoantigen and trigger autoimmune reactions within the thymus gland. This stimulates the production of autoantibodies, thus causing myasthenia gravis. The thymus is abnormal in ~75% of patients with AChR antibody-positive MG. In these cases, the thymus is hyperplastic. 10% of the patients show symptoms of thymoma.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "C. Myoid cells in thymus serve as the source of autoantigens"
  },
  {
    "id": 1461,
    "text": "Q5. 55-year old woman presented with shortness of breath, cough with expectoration and fever for ten days. Chest x-ray revealed mediastinal widening. CECT chest showed a well-circumscribed heterogeneous solid enhancing mass lesion. FNAC showed features in favor of thymoma. Which of the following is not associated with this condition?",
    "options": [
      {
        "label": "A",
        "text": "Myasthenia gravis",
        "correct": false
      },
      {
        "label": "B",
        "text": "Addison&apos;s disease",
        "correct": false
      },
      {
        "label": "C",
        "text": "Systemic lupus erythematosus",
        "correct": false
      },
      {
        "label": "D",
        "text": "Hypergammaglobulinemia",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Thymoma is associated with hypogammaglobulinemia, not hypergammaglobulinemia. Thymoma with hypogammaglobulinemia is also called Good‚Äôs syndrome. The following conditions are associated with thymomas: ¬´ Myasthenia gravis (30%) * Pure red cell aplasia (5-8%) * Hypogammaglobulinemia (~5%) * Polymyositis ¬∞ SLE * Thyroiditis * Sjogren's syndrome * Ulcerative colitis * Addison's disease * Pernicious anemia * Scleroderma ¬¢ Panhypopituitarism * Aplastic anemia * Limbic encephalitis 1176</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Hypergammaglobulinemia"
  },
  {
    "id": 1462,
    "text": "Q6. What is not a feature of myasthenia gravis among the following?",
    "options": [
      {
        "label": "A",
        "text": "Muscle fatigue",
        "correct": false
      },
      {
        "label": "B",
        "text": "Absent deep tendon reflexes",
        "correct": true
      },
      {
        "label": "C",
        "text": "Normal pupillary reflex",
        "correct": false
      },
      {
        "label": "D",
        "text": "Ptosis",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Absent deep tendon reflex is not a feature of myasthenia gravis (MG). MG usually occurs in young females. Patients usually present with weakness and fatiguability of the muscles, which worsens on repeated use or late in the day and improves on rest. The cranial muscles, particularly the eyelids and extraocular muscles are involved early in the course of MG. Diplopia and ptosis are common initial complaints. When MG becomes generalized, the proximal muscles of the limbs are affected first. Despite the muscle weakness, the deep tendon reflexes remain normal. Snarling expression on smiling (facial weakness), nasal timbre of speech (weakness of palate and tongue), and difficulty swallowing may be seen. Bulbar weakness and respiratory depression are seen more frequently in MuSK antibody-‚Äîpositive MG. MG is an autoimmune disorder most commonly caused by antibodies against the acetylcholine receptor (AChR). These antibodies cause damage to the postsynaptic muscle membrane and increased endocytosis of the AChR. This autoimmune response against the AChR seems to be mediated by the thymus. The myoid (muscle-like) cells present in the thymus express AChRs on their surface and are postulated to provide the autoantigen which triggers this autoimmune reaction. Thymic hyperplasia is seen in 65% of the patients, and thymomas are seen in 10% of the patients. The tests which are used to confirm the diagnosis of MG include: ¬¢ Anti-AChR antibody immunoassay: 85% of myasthenic patients have detectable anti-AChR antibodies, but only 50% of patients with weakness limited to ocular muscles. The presence of anti-AChR antibodies is highly suggestive of MG, but a negative test does not exclude the disease. Antibodies to MuSK and LRP4 are found in some patients * Recurrent nerve stimulation test: MG shows a decremental response &amp;gt; 10%, while Lambert-Eaton myasthenic syndrome (LEMS) shows an incremental response * Block and jitter response on single-fiber electromyography * Positive edrophonium test: improvement of ptosis on the administration of anticholinesterase such as edrophonium * Positive ice-pack test: improvement of ptosis on the application of ice-pack on the affected eye The first line of medical management in MG is anticholinesterase drugs. Pyridostigmine 30‚Äî60 mg three to four times daily is the most commonly used drug. Patients are evaluated for associated thymic abnormalities using a CT chest. Thymectomy is considered in patients with thymoma and in generalized MG patients with anti-AChR antibodies. Immunotherapy therapy can be initiated in patients with poor control on pyridostigmine after thymectomy. Glucocorticoids, cyclosporine, or tacrolimus are generally effective within 1-3 months. Azathioprine and mycophenolate mofetil may take several months to show beneficial effects and are used for the long-term management of MG. Rituximab has shown effectiveness in patients with MuSK antibodies. Intravenous eculizumab, which binds to terminal complement component 5, is also effective. Myasthenic crisis is the life-threatening exacerbation of MG leading to respiratory failure. Treatment for myasthenic crisis should take place in intensive care units. It is important to rule out excessive anticholinesterase medication as a cause of deterioration by temporarily discontinuing these drugs. Plasmapheresis and intravenous immunoglobulin (IVIg) are beneficial 1177 in hastening recovery.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "B. Absent deep tendon reflexes"
  },
  {
    "id": 1463,
    "text": "Q7. 45-year-old patient comes with complaints of progressive weakness as the day progresses. He is found to have antibodies against nicotinic acetylcholine receptors. Which is the most common ocular finding in this disease?",
    "options": [
      {
        "label": "A",
        "text": "Diplopia",
        "correct": false
      },
      {
        "label": "B",
        "text": "Lagophthalmos",
        "correct": false
      },
      {
        "label": "C",
        "text": "Exophthalmos",
        "correct": false
      },
      {
        "label": "D",
        "text": "Ptosis 1171",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">The given clinical scenario is suggestive of myasthenia gravis and ptosis is the most common ocular feature of the disease. Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction most commonly caused by anti-acetylcholine receptor antibodies. The disorder is characterized by weakness and fatigability of skeletal muscles where the weakness increases during repeated use and may improve following rest. Ptosis and diplopia are common initial complaints due to early involvement of the lids and extraocular muscles (EOMs). Of them, Ptosis is a more common manifestation than diplopia. Ptosis in myasthenia gravis is insidious, bilateral, and frequently asymmetrical. Investigations of myasthenia gravis include: * Ice pack test -This tests for a transient improvement of the ptotic eyelid on placing an ice pack for 2 minutes, as the cold inhibits the breakdown of acetylcholine by acetylcholinesterase. * Tensilon (Edrophonium) test - This tests for a transient improvement in the weakness on administration of a short-acting anticholinesterase such as edrophonium. ¬´ Antibody testing - for Acetylcholine receptor (AChR) antibodies, MuSK protein antibodies helps support a diagnosis of myasthenia gravis.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Ptosis 1171"
  },
  {
    "id": 1464,
    "text": "Q8. Which of the following features would you not expect to see in patients with ocular myasthenia?",
    "options": [
      {
        "label": "A",
        "text": "Ptosis may switch from one eye to the other over time",
        "correct": false
      },
      {
        "label": "B",
        "text": "Manually raising the more ptotic lid causes increased ptosis on the opposite side",
        "correct": false
      },
      {
        "label": "C",
        "text": "Extraocular muscle involvement produces binocular diplopia",
        "correct": false
      },
      {
        "label": "D",
        "text": "Pupils are affected in 50% of the cases",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">The pupils are always spared in myasthenia gravis (MG), differentiating it from other disorders marked by similar ocular symptoms (e. g. botulism) If weakness remains restricted to the extraocular muscles for 3 years, it is likely that it will not become generalized. These patients are said to have ocular MG. Ptosis and/or diplopia are the initial symptoms of MG in up to 85% of patients. The ptosis may increase with sustained upward gaze or by holding up the opposite eyelid with the examiner's finger (curtain sign). Cogan lid twitch is characteristic of MG. It refers to a brief overshoot twitch of the lid when the patient is made to gaze upwards after a period of downgaze. RNS studies (repetitive nerve stimulation) and anti-AChR antibodies are often negative. Single-fiber EMG (SFEMG) testing may be required for confirming the diagnosis in seronegative patients.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Pupils are affected in 50% of the cases"
  },
  {
    "id": 1465,
    "text": "Q9. Which of the following conditions is not associated with congenital myasthenic syndrome?",
    "options": [
      {
        "label": "A",
        "text": "Slow-channel congenital myasthenic syndrome",
        "correct": false
      },
      {
        "label": "B",
        "text": "Fast-channel congenital myasthenic syndrome",
        "correct": false
      },
      {
        "label": "C",
        "text": "Endplate acetylcholinesterase deficiency",
        "correct": false
      },
      {
        "label": "D",
        "text": "Dysferlin deficiency",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">1178 Dysferlin deficiency is not associated with congenital myasthenic syndrome (CMS). CMS is an uncommon cause of neuromuscular junction failure in newborns. In CMS, the immune system is unaffected. The common syndromes associated with CMS are as follows: * Slow-channel congenital myasthenic syndrome (SCCMS) * Fast-channel congenital myasthenic syndrome (FCCMS) * Primary acetylcholine receptor deficiency ¬¢ Endplate acetylcholinesterase deficiency</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Dysferlin deficiency"
  },
  {
    "id": 1466,
    "text": "Q10. 65-year-old man who is a laborer presents with progressive weakness of the legs. He says that the weakness is more in the morning and as the day progresses, it improves for a while usually. He is a known smoker. Examination reveals diminished deep tendon reflexes in the lower limbs. Which of the following statements is true regarding this condition?",
    "options": [
      {
        "label": "A",
        "text": "Depletion of presynaptic acetylcholine vesicles",
        "correct": false
      },
      {
        "label": "B",
        "text": "No immunological involvement",
        "correct": false
      },
      {
        "label": "C",
        "text": "Paraneoplastic syndrome seen in lung adenocarcinoma",
        "correct": false
      },
      {
        "label": "D",
        "text": "Incremental response on repetitive nerve stimulation",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">The given scenario is suggestive of Lambert-Eaton myasthenic syndrome (LEMS). Incremental response to repetitive nerve stimulation is a feature of this condition. LEMS is a neuromuscular junction disorder associated with the reduced acetylcholine (Ach) release from the presynaptic nerve terminals, despite normal ACh vesicle numbers. Antibodies directed against the P/Q voltage-gated calcium channel (VGCC) interfere with the normal calcium flux required for the release of acetylcholine. Approximately 50% of LEMS cases are associated with malignancy, mainly small cell lung cancer (SCLC). Most patients with LEMS present with symptoms as slowly progressive proximal muscle weakness. In LEMS, the weakness improves for a while after exertion. Diminished or absent deep tendon reflexes help differentiate between LEMS and myasthenia gravis. An increase in the compound muscle action potential (CAMP) amplitude &amp;gt; 100% after exercise or with high-frequency repetitive nerve stimulation (RNS) is considered to be of diagnostic significance.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Incremental response on repetitive nerve stimulation"
  },
  {
    "id": 1467,
    "text": "Q11. For diagnosing patients with suspected myasthenia gravis, which of the following tests has the highest sensitivity?",
    "options": [
      {
        "label": "A",
        "text": "Single-fiber electromyography 1172",
        "correct": true
      },
      {
        "label": "B",
        "text": "Repetitive nerve stimulation",
        "correct": false
      },
      {
        "label": "C",
        "text": "AChR antibodies",
        "correct": false
      },
      {
        "label": "D",
        "text": "Edrophonium test",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Single-fiber electromyography has the highest sensitivity for the diagnosis of myasthenia gravis. The tests used in the diagnosis of myasthenia gravis are: * Testing for autoantibodies against the acetylcholine receptor (AChR-Ab) should be performed on all patients (most specific). * If the AChR-Abs test negative, an assay for antibodies against muscle-specific receptor tyrosine kinase (MuSK) should be performed. * Single-fiber electromyography (SFEMG) simultaneously records action potentials of two muscle fibers innervated by the same motor axon. The variability in time of the second action potential relative to the first is called \"jitter\" and this is increased in myasthenia gravis. 1179 * Repetitive nerve stimulation (RNS) is considered abnormal if there is a decremental response of &amp;¬•t310%. * The edrophonium (\"Tensilon\") test should be used for diagnosis only in those patients with obvious ptosis or ophthalmoparesis and is not confirmatory. This test is not used routinely. Electrophysiological (RNS/SFEMG) tests are used to diagnose patients affected with seronegative myasthenia gravis.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "A. Single-fiber electromyography 1172"
  },
  {
    "id": 1468,
    "text": "Q12. Which of the following is the first line drug of choice in a patient with myasthenia gravis?",
    "options": [
      {
        "label": "A",
        "text": "Azathioprine",
        "correct": false
      },
      {
        "label": "B",
        "text": "Prednisone",
        "correct": false
      },
      {
        "label": "C",
        "text": "Intravenous immunoglobulin",
        "correct": false
      },
      {
        "label": "D",
        "text": "Pyridostigmine",
        "correct": true
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Pyridostigmine is the first-line drug of choice in the treatment of symptomatic myasthenia gravis. Treatment for myasthenia gravis involves: ¬¢ Symptomatic treatment: Anticholinesterase agents ‚Äî Pyridostigmine is the initial therapy of choice. * Chronic immunomodulating therapy: Glucocorticoids (prednisone) and immunosuppressive drugs (azathioprine, mycophenolate mofetil, cyclosporine) implemented in patients significantly symptomatic on pyridostigmine. * Rapid immunomodulating treatment: IVIG and therapeutic plasma exchange‚ÄîUsed to tide over severe illness (myasthenic crisis) and as 'bridge' therapy before surgery, or starting chronic immunomodulating treatment. ¬¢ Surgical approach: Thymectomy</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "D. Pyridostigmine"
  },
  {
    "id": 1469,
    "text": "Q13. Which of the following statements is true regarding thymectomy in patients with generalized myasthenia gravis?",
    "options": [
      {
        "label": "A",
        "text": "Indicated in most AChR-Ab positive patients with generalized myasthenia gravis",
        "correct": true
      },
      {
        "label": "B",
        "text": "Contraindicated in medication-contolled patients",
        "correct": false
      },
      {
        "label": "C",
        "text": "Induces rapid remission from disease",
        "correct": false
      },
      {
        "label": "D",
        "text": "Indicated exclusively in patients with thymomatous myasthenia gravis",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Thymectomy is indicated in most AChR-Ab positive patients with generalized myasthenia gravis Thymectomy is recommended for all patients aged &amp;lt; 60 years with non-thymomatous, acetylcholine receptor (AChR) antibody-associated generalized myasthenia gravis. Significant improvement in symptoms is expected within one year after thymectomy. It is indicated in all patients with thymoma if resection is feasible, regardless of the subtype of myasthenia gravis.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "A. Indicated in most AChR-Ab positive patients with generalized myasthenia gravis"
  },
  {
    "id": 1470,
    "text": "Q14. female patient with myasthenia gravis was admitted with complaints of sore throat, fever, cough, and weakness. She had a history of repeated hospital admissions due to exacerbation of myasthenia gravis. During some of the episodes, she even required intubation. Blood culture on admission revealed MRSA infection. Which of the following drugs can be safely administered to this patient for treating the infection?",
    "options": [
      {
        "label": "A",
        "text": "Vancomycin",
        "correct": false
      },
      {
        "label": "B",
        "text": "Clindamycin",
        "correct": false
      },
      {
        "label": "C",
        "text": "Daptomycin",
        "correct": true
      },
      {
        "label": "D",
        "text": "Gentamicin",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Daptomycin can be safely administered to treat the patient's MRSA infection. This is because it is not known to unmask or worsen the symptoms of myasthenia gravis. Drugs that may unmask or worsen myasthenia gravis include: ¬´ Anesthetic agents: Neuromuscular-blocking agents ¬¢ Antibiotics: 1180 ¬´ Aminoglycosides (eg. , gentamicin, neomycin, tobramycin) * Clindamycin * Fluoroquinolones (eg. , ciprofloxacin, levofloxacin, norfloxacin) * Ketolides (eg. , telithromycin) ¬¢ Vancomycin * Cardiovascular drugs: * Beta-blockers (eg. , atenolol, labetalol, metoprolol, propranolol) * Procainamide * Quinidine ¬¢ Other drugs: * Botulinum toxin * Chloroquine * Hydroxychloroquine * Magnesium * Penicillamine * Quinine</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "C. Daptomycin"
  },
  {
    "id": 1471,
    "text": "Q15. 1173 Patients with myasthenia gravis are resistant to anesthesia with which of the following drugs?",
    "options": [
      {
        "label": "A",
        "text": "Depolarizing agents",
        "correct": true
      },
      {
        "label": "B",
        "text": "Non-depolarizing agents",
        "correct": false
      },
      {
        "label": "C",
        "text": "Local anesthetics",
        "correct": false
      },
      {
        "label": "D",
        "text": "Inhalation anesthetics",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Patients with myasthenia gravis are resistant to neuromuscular blockade with depolarizing NMBAs (e. g. , succinylcholine), possibly because they have a decreased number of acetylcholine receptors. Local anesthetics and inhalation anesthetics are usually well-tolerated in myasthenia gravis with occasional exacerbations.</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "A. Depolarizing agents"
  },
  {
    "id": 1472,
    "text": "Q16. All of the following are the drugs that are used for the treatment of patients with myasthenia gravis. Which of the following does not alter the disease process?",
    "options": [
      {
        "label": "A",
        "text": "Pyridostigmine ee ee ee ee ee ee ee ee ee ee ee ee ee Ce ee ee ee ee ee ee 1174",
        "correct": true
      },
      {
        "label": "B",
        "text": "Prednisone",
        "correct": false
      },
      {
        "label": "C",
        "text": "Mycophenolate mofetil",
        "correct": false
      },
      {
        "label": "D",
        "text": "Azathioprine",
        "correct": false
      }
    ],
    "imageData": null,
    "explanationHTML": "<div class=\"explanation\">Pyridostigmine is an anticholinesterase agent that does not alter the disease process of myasthenia gravis. Anticholinesterase agents improve muscle contractions by allowing released acetylcholine to accumulate and act on the receptors over a large area and also have the additional direct depolarizing effect on the motor endplate. They do not alter the disease process but provide symptomatic relief. The underlying disease process continues and ultimately it may not be possible to restore muscle strength with anticholinesterase agents alone. It is due to the reduction of the receptors by the antibodies. 1181 Drugs like prednisone, mycophenolate mofetil, and azathioprine are immunosuppressive agents that reduce the antibody titers and can modify the disease process. 1182</div><div class=\"telegram-link\"><small><a href=\"http://t.me/Friendly_neighborhood_medico_bot\"> </a></small></div>",
    "subdeck": "79_Myasthenia gravis and Other Neuromuscular Junct...",
    "deck_id": 1755954606900,
    "correctAnswer": "A. Pyridostigmine ee ee ee ee ee ee ee ee ee ee ee ee ee Ce ee ee ee ee ee ee 1174"
  }
];
        let currentQuestion = 0;
        let answers = [];
        let correctCount = 0;
        let incorrectCount = 0;
        let answeredQuestions = new Set();
        let isTestMode = localStorage.getItem('testMode') === 'true' || false;

        console.log('Quiz loaded with', questions.length, 'questions');
        console.log('Test mode:', isTestMode);

        // Hide stats bar if test mode is enabled
        if (isTestMode) {
            document.addEventListener('DOMContentLoaded', () => {
                document.getElementById('stats-bar').style.display = 'none';
            });
        }

        // Auto-start quiz
        startQuiz();

        function startQuiz() {
            answers = new Array(questions.length).fill(null);
            correctCount = 0;
            incorrectCount = 0;
            answeredQuestions = new Set();
            currentQuestion = 0;
            showQuestion(0);
            updateStats();
        }

        function showQuestion(index) {
            currentQuestion = index;
            const question = questions[index];

            document.getElementById('question-number').textContent = `Question ${index + 1} of ${questions.length}`;
            document.getElementById('question-text').innerHTML = question.text;
            document.getElementById('question-status').textContent = answers[index] ? 'Question answered' : 'Click an option to answer';

            const imagesContainer = document.getElementById('question-images');
            imagesContainer.innerHTML = '';

            if (question.imageData) {
                const img = document.createElement('img');
                img.src = `data:${question.imageData.mime};base64,${question.imageData.data}`;
                img.className = 'medical-image';
                img.alt = 'Medical Question Image';
                imagesContainer.appendChild(img);
            }

            const optionsContainer = document.getElementById('options');
            optionsContainer.innerHTML = '';

            question.options.forEach(option => {
                const button = document.createElement('button');
                button.className = 'option-card w-full p-6 text-left bg-white rounded-xl shadow-lg';
                button.innerHTML = `<span class="font-bold text-blue-600 mr-4">${option.label}.</span>${option.text}`;

                if (!isTestMode && answers[index] !== null) {
                    button.disabled = true;
                    if (option.correct) {
                        button.classList.add('correct');
                    } else if (answers[index] === option.label) {
                        button.classList.add('incorrect');
                    }
                } else {
                    button.onclick = () => selectAnswer(option.label);
                }

                if (answers[index] === option.label) {
                    button.classList.add('selected');
                }

                optionsContainer.appendChild(button);
            });

            // Show feedback only in normal mode and if answered
            if (!isTestMode && answers[index] !== null) {
                showFeedback(index);
            } else {
                document.getElementById('feedback-section').classList.add('hidden');
            }

            document.getElementById('prev-btn').disabled = index === 0;

            if (answers[index] !== null) {
                if (index === questions.length - 1) {
                    document.getElementById('next-btn').classList.add('hidden');
                    document.getElementById('finish-btn').classList.remove('hidden');
                } else {
                    document.getElementById('next-btn').classList.remove('hidden');
                    document.getElementById('finish-btn').classList.add('hidden');
                }
            } else {
                document.getElementById('next-btn').classList.add('hidden');
                document.getElementById('finish-btn').classList.add('hidden');
            }

            const progress = ((index + 1) / questions.length) * 100;
            document.getElementById('progress-bar').style.width = `${progress}%`;
        }

        function selectAnswer(label) {
            const question = questions[currentQuestion];
            const correctOption = question.options.find(opt => opt.correct);
            const isCorrect = correctOption && label === correctOption.label;

            if (!answeredQuestions.has(currentQuestion)) {
                answeredQuestions.add(currentQuestion);
                if (isCorrect) {
                    correctCount++;
                } else {
                    incorrectCount++;
                }
            }

            answers[currentQuestion] = label;
            updateStats();
            
            showQuestion(currentQuestion);
        }

        function showFeedback(questionIndex) {
            const question = questions[questionIndex];
            const userAnswer = answers[questionIndex];
            const correctOption = question.options.find(opt => opt.correct);
            const userOption = question.options.find(opt => opt.label === userAnswer);
            const isCorrect = correctOption && userAnswer === correctOption.label;

            const feedbackSection = document.getElementById('feedback-section');
            const feedbackIcon = document.getElementById('feedback-icon');
            const feedbackMessage = document.getElementById('feedback-message');

            if (isCorrect) {
                feedbackSection.className = 'bg-green-50 border border-green-200 mb-8 p-6 rounded-2xl';
                feedbackIcon.textContent = '‚úÖ';
                feedbackMessage.textContent = 'Correct!';
                feedbackMessage.className = 'text-2xl font-bold mb-2 text-green-700';
            } else {
                feedbackSection.className = 'bg-red-50 border border-red-200 mb-8 p-6 rounded-2xl';
                feedbackIcon.textContent = '‚ùå';
                feedbackMessage.textContent = 'Incorrect';
                feedbackMessage.className = 'text-2xl font-bold mb-2 text-red-700';
            }

            document.getElementById('user-answer-display').innerHTML = `<span class="${isCorrect ? 'text-green-600' : 'text-red-600'}">${userAnswer}. ${userOption?.text || 'Unknown'}</span>`;
            document.getElementById('correct-answer-display').textContent = question.correctAnswer;

            const explanationSection = document.getElementById('explanation-section');
            if (question.explanationHTML && question.explanationHTML.trim()) {
                document.getElementById('explanation-content').innerHTML = question.explanationHTML;
                explanationSection.classList.remove('hidden');
            } else {
                explanationSection.classList.add('hidden');
            }

            feedbackSection.classList.remove('hidden');
        }

        function updateStats() {
            const totalAnswered = correctCount + incorrectCount;
            const accuracy = totalAnswered === 0 ? 0 : Math.round((correctCount / totalAnswered) * 100);

            document.getElementById('correct-stats').textContent = correctCount;
            document.getElementById('incorrect-stats').textContent = incorrectCount;
            document.getElementById('accuracy-stats').textContent = `${accuracy}%`;
            document.getElementById('progress-stats').textContent = `${totalAnswered}/${questions.length}`;
        }

        document.getElementById('prev-btn').onclick = () => {
            if (currentQuestion > 0) {
                showQuestion(currentQuestion - 1);
            }
        };
        
        document.getElementById('next-btn').onclick = () => {
            if (currentQuestion < questions.length - 1) {
                showQuestion(currentQuestion + 1);
            }
        };
        
        document.getElementById('finish-btn').onclick = showFinalResults;

        function showFinalResults() {
            if (isTestMode) {
                showTestModeResults();
            } else {
                showNormalModeResults();
            }
        }

        function showTestModeResults() {
            const accuracy = (correctCount + incorrectCount === 0) ? 0 : Math.round((correctCount / (correctCount + incorrectCount)) * 100);

            document.getElementById('quiz-section').classList.add('hidden');
            document.getElementById('test-results').classList.remove('hidden');

            document.getElementById('test-final-correct').textContent = correctCount;
            document.getElementById('test-final-incorrect').textContent = incorrectCount;
            document.getElementById('test-final-accuracy').textContent = `${accuracy}%`;

            let gradeIcon = 'üéØ';
            if (accuracy >= 90) {
                gradeIcon = 'üèÜ';
            } else if (accuracy >= 80) {
                gradeIcon = 'üéâ';
            } else if (accuracy >= 70) {
                gradeIcon = 'üëç';
            } else if (accuracy >= 60) {
                gradeIcon = 'üìö';
            } else {
                gradeIcon = 'üí™';
            }

            document.getElementById('test-grade-icon').textContent = gradeIcon;

            // Show detailed review
            const reviewContainer = document.getElementById('test-review-details');
            reviewContainer.innerHTML = '';

            questions.forEach((question, index) => {
                const userAnswer = answers[index];
                const correctOption = question.options.find(opt => opt.correct);
                const userOption = question.options.find(opt => opt.label === userAnswer);
                const isCorrect = correctOption && userAnswer === correctOption.label;

                const reviewCard = document.createElement('div');
                reviewCard.className = `border-l-4 p-4 bg-white rounded-lg shadow-sm ${isCorrect ? 'border-green-500' : 'border-red-500'}`;
                
                reviewCard.innerHTML = `
                    <div class="flex items-center justify-between mb-2">
                        <h4 class="font-bold text-gray-800">Question ${index + 1}</h4>
                        <span class="text-2xl">${isCorrect ? '‚úÖ' : '‚ùå'}</span>
                    </div>
                    <p class="text-gray-700 mb-3">${question.text}</p>
                    <div class="grid md:grid-cols-2 gap-4">
                        <div>
                            <strong class="text-gray-600">Your Answer:</strong><br>
                            <span class="${isCorrect ? 'text-green-600' : 'text-red-600'}">${userAnswer}. ${userOption?.text || 'Not answered'}</span>
                        </div>
                        <div>
                            <strong class="text-gray-600">Correct Answer:</strong><br>
                            <span class="text-green-600">${question.correctAnswer}</span>
                        </div>
                    </div>
                    ${question.explanationHTML ? `
                        <div class="mt-3 p-3 bg-blue-50 rounded-lg">
                            <strong class="text-blue-800">Explanation:</strong>
                            <div class="mt-2 explanation-content">${question.explanationHTML}</div>
                        </div>
                    ` : ''}
                `;
                
                reviewContainer.appendChild(reviewCard);
            });
        }

        function showNormalModeResults() {
            const accuracy = (correctCount + incorrectCount === 0) ? 0 : Math.round((correctCount / (correctCount + incorrectCount)) * 100);

            document.getElementById('quiz-section').classList.add('hidden');
            document.getElementById('final-results').classList.remove('hidden');

            document.getElementById('final-correct').textContent = correctCount;
            document.getElementById('final-incorrect').textContent = incorrectCount;
            document.getElementById('final-accuracy').textContent = `${accuracy}%`;

            let gradeIcon = 'üéØ';
            if (accuracy >= 90) {
                gradeIcon = 'üèÜ';
            } else if (accuracy >= 80) {
                gradeIcon = 'üéâ';
            } else if (accuracy >= 70) {
                gradeIcon = 'üëç';
            } else if (accuracy >= 60) {
                gradeIcon = 'üìö';
            } else {
                gradeIcon = 'üí™';
            }

            document.getElementById('final-grade-icon').textContent = gradeIcon;
        }
    </script>
</body>
</html>